- Home
- BWAY vs ARTV Comparison
BWAY vs ARTV Comparison
Compare BWAY & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- ARTV
- Stock Information
- Founded
- BWAY 2003
- ARTV 2019
- Country
- BWAY Israel
- ARTV United States
- Employees
- BWAY N/A
- ARTV N/A
- Industry
- BWAY Medical/Dental Instruments
- ARTV
- Sector
- BWAY Health Care
- ARTV
- Exchange
- BWAY Nasdaq
- ARTV NYSE
- Market Cap
- BWAY 207.4M
- ARTV 186.1M
- IPO Year
- BWAY 2019
- ARTV 2024
- Fundamental
- Price
- BWAY $10.21
- ARTV $5.60
- Analyst Decision
- BWAY Strong Buy
- ARTV Strong Buy
- Analyst Count
- BWAY 3
- ARTV 6
- Target Price
- BWAY $13.17
- ARTV $21.00
- AVG Volume (30 Days)
- BWAY 92.0K
- ARTV 80.2K
- Earning Date
- BWAY 03-11-2025
- ARTV 03-25-2025
- Dividend Yield
- BWAY N/A
- ARTV N/A
- EPS Growth
- BWAY N/A
- ARTV N/A
- EPS
- BWAY 0.09
- ARTV N/A
- Revenue
- BWAY $41,016,000.00
- ARTV $2,601,000.00
- Revenue This Year
- BWAY $349.63
- ARTV N/A
- Revenue Next Year
- BWAY $27.16
- ARTV N/A
- P/E Ratio
- BWAY $66.18
- ARTV N/A
- Revenue Growth
- BWAY 29.04
- ARTV N/A
- 52 Week Low
- BWAY $4.61
- ARTV $3.37
- 52 Week High
- BWAY $11.79
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- BWAY 52.70
- ARTV N/A
- Support Level
- BWAY $8.88
- ARTV N/A
- Resistance Level
- BWAY $10.54
- ARTV N/A
- Average True Range (ATR)
- BWAY 0.58
- ARTV 0.00
- MACD
- BWAY 0.03
- ARTV 0.00
- Stochastic Oscillator
- BWAY 68.98
- ARTV 0.00
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.